Regen BioPharma, Inc.
RGBP
$0.00
$0.00-50.00%
OTC PK
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 991.90K | -967.90K | -572.50K | -167.30K | -19.40K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 8.70K | 8.90K | 34.20K | -7.40K | 12.60K |
| Total Other Non-Cash Items | -1.16M | 780.80K | 323.60K | 474.80K | -129.00K |
| Change in Net Operating Assets | 97.40K | -19.80K | 54.60K | -356.10K | 34.40K |
| Cash from Operations | -63.20K | -197.90K | -160.00K | -56.00K | -101.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | 119.60K | 56.00K | 102.90K |
| Total Debt Repaid | 8.90K | -58.80K | -- | -- | -- |
| Issuance of Common Stock | 50.00K | 191.80K | 58.20K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 50.00K | -- | -- |
| Cash from Financing | 58.90K | 133.00K | 227.80K | 56.00K | 102.90K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Net Change in Cash | -4.30K | -65.00K | 67.80K | 0.00 | 1.60K |